Lumexa Imaging Holdings, Inc. (LMRI) shares declined 15.24 percent, down $1.69 to $9.38 on Thursday, after the company reported a 2025 net loss of $47.1 million, compared with a net loss of $94.1 million in 2024, as higher revenue and affiliate earnings improved operating performance. EPS showed a loss of $0.66 for 2025 versus a loss of $1.35 a year earlier, while fourth-quarter EPS was a loss of $0.38 compared with a loss of $0.36 in the prior-year quarter.
The stock is currently trading at $9.38, below its previous close of $11.06, after opening at $8.40. Shares traded in a range of $8.40 to $10.92 during the session on the Nasdaq, with volume at 0.56 million shares, compared with an average daily volume of 0.70 million.
Total revenue increased to $1.02 billion in 2025 from $948.9 million in 2024, driven by net patient service revenue rising to $802.7 million from $746.9 million, while management fee and other revenue increased to $220.4 million from $202.0 million.
Lumexa Imaging's 52-week range is $8.40 to $19.45.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.